Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
Abstract Background Dalbavancin is a lipoglycopeptide antibiotic approved for treatment of skin and soft tissue infections, administered as a single or two-dose treatment. The extended half-life, good penetration into bone and synovial fluid, and bactericidal activity against gram-positive bacteria,...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2023-10-01
|
| Edice: | BMC Infectious Diseases |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12879-023-08709-8 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|